4.8 Article

Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

Journal

CELL
Volume 165, Issue 2, Pages 449-463

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2016.02.022

Keywords

-

Funding

  1. Division of AIDS, NIAID, NIH Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery [UM1 AI100645]
  2. Scripps CHAVI-ID [UM1 AI100663]
  3. International AIDS Vaccine Initiative
  4. Bill and Melinda Gates Foundation
  5. Intramural Research Program of the Vaccine Research Center, NIAID, NIH
  6. NIH [P01-AI104722]
  7. US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]

Ask authors/readers for more resources

Antibodies with ontogenies from V(H)1-2 or V(H)1-46-germline genes dominate the broadly neutralizing response against the CD4-binding site (CD4bs) on HIV-1. Here, we define with longitudinal sampling from time-of-infection the development of a V(H)1-46-derived antibody lineage that matured to neutralize 90% of HIV-1 isolates. Structures of lineage antibodies CH235 (week 41 from time-of-infection, 18% breadth), CH235.9 (week 152, 77%), and CH235.12 (week 323, 90%) demonstrated the maturing epitope to focus on the conformationally invariant portion of the CD4bs. Similarities between CH235 lineage and five unrelated CD4bs lineages in epitope focusing, length-of-time to develop breadth, and extraordinary level of somatic hypermutation suggested commonalities in maturation among all CD4bs antibodies. Fortunately, the required CH235-lineage hypermutation appeared substantially guided by the intrinsic mutability of the V(H)1-46 gene, which closely resembled V(H)1-2. We integrated our CH235-lineage findings with a second broadly neutralizing lineage and HIV-1 co-evolution to suggest a vaccination strategy for inducing both lineages.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available